Company Overview
SUNSHINE BIOPHARMA INC.
SBFMRevenue vs. Cost of Revenue
Revenue
Cost of Revenue
Total Operating Expenses vs. Operating Income
Total Operating Expenses
Operating Income
Net Income
Net Income
Revenue
35M
2024 FY
Net Income
-5M
2024 FY
Shares Outstanding
1M
2024 FY
EPS
-7.32USD
2024 FY
Company Information
SIC Code
2834
CIK Code
1402328
Exchange
Nasdaq
Location
CA